AEterna Zentaris Inc (NASDAQ:AEZS)

1.88
Delayed Data
As of Feb 23
 -0.01 / -0.53%
Today’s Change
0.78
Today|||52-Week Range
3.75
-20.34%
Year-to-Date
No recent news for AEterna Zentaris Inc.

Today’s Trading

Previous close1.89
Today’s open1.90
Day’s range1.85 - 1.91
Volume49,908
Average volume (3 months)602,066
Market cap$30.5M
Data as of 3:59pm ET, 02/23/2018

Growth & Valuation

Earnings growth (last year)+86.71%
Earnings growth (this year)+40.19%
Earnings growth (next 5 years)+1.00%
Revenue growth (last year)+67.16%
P/E ratioNM
Price/Sales42.25
Price/Book3.91

Competitors

 Today’s
change
Today’s
% change
PRTOProteon Therapeutics...-0.10-4.35%
IMMPImmutep Ltd0.000.00%
FSIFlexible Solutions I...+0.09+5.62%
HTGMHTG Molecular Diagno...+0.17+3.59%
Data as of 4:00pm ET, 02/23/2018

Financials

Last reporting date--
EPS forecast (this quarter)-$0.31
Annual revenue (last year)$911.0K
Annual profit (last year)-$25.0M
Net profit margin-2,739.74%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer
Michael Ward
Vice President-
Pre-Clinical Development
Michael Teifel
Corporate headquarters
Montréal, Qubec

Forecasts